Private Equity Firm Financial Services

Hayfin

London, United Kingdom

Leading alternative asset manager investing in private markets strategies including Direct Lending, Special Opportunities, High-Yield Credit and Private Equity Solutions, with offices across Europe and North America.

Focus Areas
Direct Lending, Special Opportunities, High-Yield Credit
Website
hayfin.com

Tracked deals

4

4 tracked deals across 2021-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Growth capital

2 growth capital · 1 buyout · 1 recapitalization

Hayfin Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Hayfin. 2 2021 1 2025 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Alantra Private Equity, Hayfin Capital Management, Mérieux Equity Partners, BNP Paribas Asset Management, AltamarCAM Partners
    Target
    Health in Code
    Seller
    Existing investors in Alantra Private Equity Fund III
    Location
    Spain

    Alantra Private Equity closed a €155 million single-asset continuation vehicle, led by Hayfin Capital Management, to increase and retain its stake in clinical genomics platform Health in Code. As part of the recapitalization Mérieux Equity Partners joined as a c.20% minority investor while existing investors in Alantra Private Equity Fund III received liquidity; the new capital and a reorganized debt facility are intended to accelerate international expansion and add-on M&A across Europe.

  • Buyer
    Charterhouse Capital Partners, Peugeot Invest, Hayfin Capital
    Target
    Novétude Group, Novétude Santé
    Industry
    Education
    Location
    Hauts-de-Seine, France

    Charterhouse Capital Partners has welcomed Peugeot Invest and Hayfin Capital as minority investors in the newly formed Novétude Group, a European healthcare education platform built around Novétude Santé. Charterhouse will retain a majority stake while the new investors provide growth capital to support international expansion and platform development across healthcare education programs.

  • Buyer
    Hayfin Capital Management LLP, Gyrus Capital
    Target
    Corcym
    Industry
    Medical Devices
    Location
    England, United Kingdom

    Corcym, a global medical device company focused on structural heart solutions, closed a €45 million growth financing arranged by funds managed by Hayfin Capital Management. The financing (preferred equity plus a senior credit facility) will support Corcym's international expansion and strategic growth initiatives alongside existing investor Gyrus Capital.

  • Buyer
    Vivalto Partners, IK Partners, Hayfin, MACSF, Arkéa Capital, BNP Paribas Développement, Groupe Crédit Agricole, Mubadala, Bpifrance
    Target
    Vivalto Santé
    Location
    Île-de-France, France
    Type
    Buyout

    Vivalto Partners has closed the acquisition of Vivalto Santé, the third-largest private hospitals group in France, bringing together 50 facilities, over 10,000 employees and more than €1 billion in annual revenue. The deal is backed by historical institutional investors (MACSF, Arkéa Capital, BNP Paribas Développement, Groupe Crédit Agricole, Mubadala and Bpifrance) and welcomes new partners IK Partners and Hayfin to support the group's next phase of growth and expanded employee/practitioner shareholding.

Related Acquisition Pages

Selling a company? Get in front of buyers like Hayfin

Turn tracked acquisition activity into an outreach-ready buyer list.